Brochure
13 Jun 2023
SINOVAC Vaccines leaflets
PDF 5.5 MB
Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.
Content provided by our supplier
Sinovac Biotech Ltd.
-
Country/Region:China
-
On CPHI since:2018
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Other Content from Sinovac Biotech Ltd. (1)
-
News SINOVAC Named BogotáBio Exclusive Partner, Fueling New Vaccine Advances in Colombia
Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it has been named the exclusive strategic partner of BogotáBio, which will break ground as the first local human vaccine production facility to be established in Colombia’s capital city of Bogota.